Histopathology Services to Support On-going Small Animal Product Efficacy Studies for Viruses with Pandemic Potential
ID: RFQ-NIAID-24-2226993Type: Combined Synopsis/Solicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH NIAIDBETHESDA, MD, 20892, USA

NAICS

Veterinary Services (541940)

PSC

MEDICAL- LABORATORY TESTING (Q301)

Original Source

https://sam.gov/opp/f546a27f816b4b9892521e4748cf0991/view
Timeline
    Description

    The Department of Health and Human Services, through the National Institutes of Health (NIH), is seeking qualified vendors to provide histopathology services to support ongoing small animal product efficacy studies for viruses with pandemic potential. The procurement aims to engage professional services for preparing and evaluating hematoxylin and eosin (H&E) stained slides from infected tissues, which are critical for assessing the efficacy of candidate vaccines and therapeutics. This initiative underscores the importance of rigorous scientific evaluations in pandemic preparedness, with a contract that includes a base quantity of five studies and options for up to 30 additional studies. Interested vendors must submit their quotes by 3:00 PM ET on September 13, 2024, to Seth Schaffer at seth.schaffer@nih.gov, with the solicitation number RFQ-NIAID-24-2226993.

    Point(s) of Contact
    Seth Schaffer
    (301) 761-6205
    seth.schaffer@nih.gov
    Linda Smith
    linda.smith2@nih.gov
    Files
    Title
    Posted
    RFQ Attachment 1 - SOW.pdf
    The document outlines an RFP aimed at procuring veterinary histopathology services to support U.S. government efforts against viruses with pandemic potential, particularly through the evaluation of small animal product efficacy studies. A core requirement is the analysis of H&E-stained slides prepared from infected tissues, with the contractor responsible for logging shipments, conducting microscopic evaluations, and producing comprehensive pathology reports with photomicrographs. The contract includes five base studies with options for up to 30 additional studies, emphasizing the expertise of veterinary pathologists with relevant credentials and experience. The document details reporting requirements, quality control measures, and a timeline for draft and final report submissions to the NIAID. Evaluation of proposals will focus on technical qualifications over cost, favoring contractors capable of delivering high-quality pathology evaluations promptly. The structure includes a scope of services, testing requirements, contractor qualifications, delivery schedules, evaluation factors, and inspection processes, reinforcing the government’s commitment to effective pandemic preparedness through rigorous scientific evaluations.
    RFQ Attachment 2 - FAR 52.212-5 Full Text.pdf
    The document details the Federal Acquisition Regulation (FAR) clause 52.212-5, which outlines the contract terms and conditions necessary for implementing federal laws and executive orders applicable to commercial products and services. It specifies required clauses that contractors must adhere to, addressing regulations related to confidentiality agreements, prohibitions on contracting with certain entities, requirements for small business participation, employment regulations, and more. The structure of the document organizes clauses into sections based on their purpose, such as compliance with labor standards, ethical conduct, and security measures. It emphasizes the importance of various provisions, including the prohibition of potential security threats, equal opportunity employment, and regulations on subcontracting practices. This summary underscores the document's role in ensuring that federal contractors meet legal, ethical, and operational standards crucial for successful contract execution. The overarching aim is to promote responsible contracting practices while enhancing compliance with federal laws across all associated acquisitions.
    RFQ Attachment 3 - QA.pdf
    The file details a request for proposals (RFP) regarding histopathology services to support ongoing small animal product efficacy studies for viruses with pandemic potential, identified by Notice ID: RFQ-NIAID-24-2226993. The document includes a series of questions and answers aimed at clarifying the bidding process. The government anticipates a lead time of about two weeks between study notification and receipt for vendors. Additionally, studies may be received in batches, although the government will prioritize assignments, allowing for staggered completion rather than requiring simultaneous study deliveries. This RFP aims to ensure efficient and timely histopathological analysis to support research on potential viral threats, reflecting a proactive approach in public health preparedness.
    Similar Opportunities
    Sources Sought-BioFire Reagents and Test Kits
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is conducting a Sources Sought announcement to identify potential qualified small businesses capable of supplying BioFire Defense reagents and test kits. The NIH's Department of Laboratory Medicine requires these reagents for their BioFire FilmArray analyzers, which are essential for the rapid detection of infectious agents from clinical samples, thereby facilitating timely treatment. Interested vendors must submit their company information, including a capability statement, by 12:00 PM EST on November 7, 2024, to Sheri Eiri at sheri.eiri@nih.gov, as the government will not reimburse any costs associated with this request.
    CYTEK AURORA 5 LASER PREMIUM SERVICE AGREEMENT
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified contractors to provide a premium service agreement for the Cytek Aurora 5 Laser systems. The procurement includes essential services such as preventive maintenance inspections, technical support, and on-site assistance for four specific Cytek Aurora 5 Laser units, ensuring optimal performance and reliability during the contract period from March 1, 2025, to February 28, 2026. This service agreement is critical for maintaining the functionality of laboratory equipment used in vital research, reflecting the NIH's commitment to supporting scientific advancements. Interested vendors must submit their quotations via the NIAID electronic Simplified Acquisition Submission System (eSASS) by November 12, 2024, at 12:00 am EST, and can contact Maliaka Pinkney at maliaka.pinkney@nih.gov for further inquiries.
    Title: Global Life Sciences Sepax Cell Separation Kits
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to award a firm fixed-price contract for the procurement of Global Life Sciences Sepax Cell Separation Kits and Ficoll Paque Premium reagents. The NIH's Department of Transfusion Medicine requires these items to support the manufacturing of cell-based therapies for patients with advanced metastatic cancer, utilizing the Sepax C-Pro Cell Processing Instruments. This acquisition is being conducted under the Simplified Acquisition Procedures, allowing for a sole-source award to Cytiva-Global Life Sciences Solutions USA LLC, with capability statements due by November 3, 2024, at 12:00 PM EST. Interested parties can direct inquiries to Sheri Eiri at sheri.eiri@nih.gov.
    NIAID CLINICAL PRODUCTS CENTER (CPC)
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking proposals for a contract to provide pharmacy and pharmaceutical oversight for clinical trials, both nationally and internationally. The primary objective of this contract is to ensure the integrity of study products, participant safety, and compliance with pharmacy and pharmaceutical regulations throughout various NIH-funded clinical trials. This opportunity is critical for maintaining high standards in public health research, as it encompasses a wide range of services including product management, regulatory document maintenance, and clinical laboratory testing. Proposals are due by January 17, 2025, with the contract expected to commence on April 1, 2026, and run through March 31, 2027, potentially extending through 2033. Interested parties can contact Deborah Blyveis at blyveisd@niaid.nih.gov or Emily Bannister at emily.bannister@nih.gov for further information.
    MAINTENANCE AND REPAIR SERVICE AGREEMENT FOR NEXTSEQ 2000 (S/N: VH74007)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to negotiate a maintenance and repair service agreement for the Illumina NextSeq 2000 system, serial number VH74007. The contract will cover a 12-month support plan, including full maintenance for parts, labor, and travel, as well as preventative maintenance inspections, remote technical support, and software updates. This service is crucial for the Laboratory of Parasitic Diseases to ensure the operational efficiency of their sequencing equipment. Interested vendors must submit their capability statements and relevant documentation by 12:00 PM EST on November 15, 2024, via the NIH electronic Simplified Acquisition Submission System (eSASS), with all inquiries directed to Mildred Moss at mildred.moss@nih.gov or Tonia Alexander at talexander@niaid.nih.gov.
    Reagent Generation for Bioanalytical Method Development on Biologics
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified sources for a potential contract focused on reagent generation for bioanalytical method development related to biologics. The primary objective is to obtain information on the availability and capability of companies to generate and deliver reagents, including anti-drug antibodies, that support the quantification of novel biologic drugs in various biological matrices. This initiative is crucial for advancing drug development processes and improving success rates in preclinical stages, with the Therapeutic Development Branch (TDB) at NIH playing a pivotal role in moving therapeutic candidates through the drug development pipeline. Interested parties must submit their capability statements by November 8, 2024, to Nick Niefeld at nick.niefeld@nih.gov, referencing sources sought notice number 75N95025R00007.
    BD Biosciences Proprietary Instrumentation Package and Reagent Kits
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to procure a proprietary instrumentation package and reagent kits from Becton, Dickinson & Company for the Department of Laboratory Medicine. This acquisition aims to secure essential supplies, including instrument rentals and quality control materials, necessary for the operation of the Hematology Flow Cytometry Service, which plays a critical role in patient care and research. The procurement is vital for maintaining the laboratory's capacity to deliver timely and accurate results, as the specified reagent kits are uniquely compatible with the existing BD Rhapsody™ single cell analysis system. Interested parties may submit capability statements to Shasheshe Goolsby at shasheshe.goolsby@nih.gov by November 14, 2024, at 6:30 AM EST, as this is a presolicitation notice and not a request for quotations.
    NIAID PROFESSIONAL, SCIENTIFIC AND TECHNICAL SUPPORT SERVICES (PSTSS)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH) NIAID, is seeking proposals for Professional, Scientific, and Technical Support Services (PSTSS) to assist with various research initiatives, including basic, translational, and clinical research, as well as vaccine development and laboratory research across multiple biosafety levels. The procurement aims to secure specialized expertise to enhance the effectiveness of ongoing and future research efforts critical to public health. Proposals are due by December 16, 2024, with the contract period set to commence on June 1, 2025, and potentially extend to November 30, 2030, with a total funding cap of $3 billion across all awarded contracts. Interested parties can reach out to Rosemary Gomes at Rosemary.Gomes@nih.gov or Kristel Turansky at Kristel.Turansky@nih.gov for further information.
    Preventative Maintenance Agreement for Sciex Triple Quad 6500 Systems
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to establish a Preventative Maintenance Agreement for two Sciex Triple Quad 6500 Systems utilized by the Department of Laboratory Medicine at the NIH Clinical Center. This contract aims to ensure optimal performance through annual preventative maintenance and timely repairs, which are critical for maintaining uninterrupted laboratory services for both clinical and research purposes. The selected vendor, Ab Sciex LLC, is the sole manufacturer of the equipment and will provide comprehensive coverage under the Sciex Assurance and Software Plus Plans, ensuring access to OEM parts and software support for a period from December 22, 2024, to December 21, 2027. Interested parties may submit capability statements to Shasheshe Goolsby at shasheshe.goolsby@nih.gov by November 8, 2024, at 6:30 AM EST, as this is not a request for proposal and the total contract value will not exceed $250,000.
    A--NIH NeuroBioBank Brain and Tissue Repository
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is soliciting proposals for the establishment of the NIH NeuroBioBank Brain and Tissue Repository under Request for Proposal (RFP) No. 75N95024R00124. The objective of this procurement is to create and manage contract collection sites for acquiring, storing, and distributing human brain and central nervous system tissues for research, aimed at advancing the understanding and treatment of nervous system disorders. This initiative is critical for enhancing biomedical research by improving access to well-characterized specimens, thereby supporting scientific investigations into neurological conditions. Proposals are due by November 14, 2024, with the anticipated contract performance period starting on May 1, 2025, and extending through optional years. Interested parties can direct inquiries to Robin D. Knightly at robin.knightly@nih.gov or call +1 301 827 5302 for further information.